Tom Patton

SV Health Investors

Thomas M. Patton has more than 25 years of experience successfully leading medical products companies, from start-ups to growth companies, both public and private. He has been the President and CEO of Wright Medical, Novametrix, QDx, CASMED and Ximedica. Patton is an experienced board member and has served on the board of more than a dozen companies, including K2M, Misonix, and Genova Diagnostics. In addition, Patton has also served as an Advisor to the healthcare focused private equity fund Ferrer Freeman and Company, and is currently an Executive-In-Residence with SV Health Investors for their SV Growth Fund 7. Patton is also currently a member of the Board of Directors of Robling Medical, Packaging Compliance Labs, ElectroCore (NASD: ECOR) and the Connecticut Port Authority. He is a graduate of the College of the Holy Cross and Georgetown University Law Center.